The roles of histone deacetylases and their inhibitors in cancer therapy

G Li, Y Tian, WG Zhu - Frontiers in cell and developmental biology, 2020 - frontiersin.org
Genetic mutations and abnormal gene regulation are key mechanisms underlying
tumorigenesis. Nucleosomes, which consist of DNA wrapped around histone cores …

Dual-target inhibitors based on HDACs: novel antitumor agents for cancer therapy

T Liu, Y Wan, Y ** anti-cancer drugs
H Jo, K Shim, HU Kim, HS Jung, D Jeoung - Computational and Structural …, 2023 - Elsevier
Histone deacetylases (HDACs) deacetylate histones H3 and H4. An imbalance between
histone acetylation and deacetylation can lead to various diseases. HDAC2 is present in the …

[HTML][HTML] HDACs and the epigenetic plasticity of cancer cells: Target the complexity

C Brancolini, T Gagliano, M Minisini - Pharmacology & therapeutics, 2022 - Elsevier
Cancer cells must adapt to the hostile conditions of the microenvironment in terms of
nutrition, space, and immune system attack. Mutations of DNA are the drivers of the …

How do tumor cells respond to HDAC inhibition?

A Newbold, KJ Falkenberg, HM Prince… - The FEBS …, 2016 - Wiley Online Library
It is now well recognized that mutations, deregulated expression, and aberrant recruitment of
epigenetic readers, writers, and erasers are fundamentally important processes in the onset …